Skip to main content

Advertisement

Table 2 Association between the expression of YAP/TAZ and Wnt pathway mutations (N = 86)

From: Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

  WNT p-value
WT MUT
N (%) N (%)
TAZneg 39 (76.5) 12 (23.5) 0.008 (Chi-squared)
TAZpos 17 (48.6) 18 (51.4)  
YAPneg 7 (70.0) 3 (30.0) 0.999 (Fisher)
YAPpos 49 (64.5) 27 (35.5)